Olayinka Adejoke Kotila

ORCID, self-asserted

ORCID 0000-0002-0674-9085

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

8 works in the graph, newest first.

Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (ARETTA)
2026JCO Global OncologyJournalOpen access0 citations10.1200/go-25-00287
Novel dietary herbal preparations with inhibitory activities against multiple SARS-CoV-2 targets: A multidisciplinary investigation into antiviral activities
2025Food Chemistry AdvancesJournalOpen access2 citations10.1016/j.focha.2025.100969
Challenges and Recommendations for Improving Cancer Research and Practice in Nigeria: A Qualitative Study With Multi-Stakeholders in Oncology Research and Practice
2024Cancer ControlJournalOpen access4 citations10.1177/10732748241298331
Building capacity for drug development process in Africa‒A workable model
2024Pharmacy EducationJournalOpen access0 citations10.46542/pe.2024.241.112
Non‐compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study
2023British Journal of Clinical PharmacologyJournalOpen accessFirst authorCorresponding3 citations10.1111/bcp.15862
The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes
2023American Journal of Pharmacotherapy and Pharmaceutical SciencesJournalOpen access2 citations10.25259/ajpps_2023_024
Oncology Training Needs Assessment Among Health Care Professionals in Nigeria
2022JCO Global OncologyJournalOpen access13 citations10.1200/go.22.00017
Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria
2022AIDS Research and TherapyJournalOpen access3 citations10.1186/s12981-022-00462-3